skip to Main Content

David E.T. Pinkman

President, Chief Executive Officer, and Director

David Pinkman BA, LLB, founded, operated and was Executive Chairman of Jupiter Power International Inc., an independent power production company which successfully built and operated a number of power plants in Cambodia and SE Asia. Mr. Pinkman has participated in the management and ownership of a number of companies in his recent career.  Previously, he was the Interim Chief Executive Officer of Synstream Energy Corp., a corporation specializing in the application of gas-to-liquids technology in the oil industry, from August 21, 2017 until December 29, 2017 and served as a director from May 2007 until present.  He is the Chief Financial Officer and a director of International SoftRock Oil Company Limited, an oil and gas E&P firm which had operations in West Africa, and has been so since February 2015. He is and has been a director of Builders Capital Mortgage Corp. since March 28, 2013. Mr. Pinkman has served on the boards of a variety of local volunteer organizations, and continues to serve as a director and Treasurer of Wild Rose Motocross Association and is a director of the Canadian Motorcycle Association.

Vincent E. Ghazar

Chief Financial Officer and Director

Mr. Ghazar has served CFO and Director of Asia Cannabis Corp. from early 2018. Mr. Ghazar has a professional accounting practice (2014 – ), is the Controller of Synstream Energy Corp. (2013 – ), and CFO and VP Finance of Standard Exploration Ltd., both public companies. He has advance training in compliance, regulatory and governance practices and has extensive IFRS and GAAP experience.

Dr. Igor Kovalchuk,  PhD


Mr. Kovalchuk has served as an Asia Cannabis Corp. Director since mid 2018. He is the co-founder of Inplanta Biotechnolgy Inc. (est. 2015), founder of genomics company Plantbiosis (est. 2010), and a (co)founder of Pathway Rx (est. 2016). Presently, he is a Professor and the Board of Governors Research Chair at the University of Lethbridge, Department of Biological Sciences (2001 – ) and Board of Governors’ Research Chair in Plant Biotechnology (2007 – ). He is also executive member and Scientific Leader of Alberta Epigenetics Network (2014 – ), and a Director of Next Generation Sequencing Facility (2010 – ).

Dr. Darryl Hudson, PhD


Dr. Hudson is a principal of InPlanta Biotechnology Inc. and received a PhD in Molecular Biology and Genetics from the University of Guelph in 2010. He has published research in diverse fields including plant biology, genetics, epigenetics, DNA repair mechanisms, and carcinogenesis. He primarily works as a consultant and researcher helping producers in many countries to optimize genetics, cultivation processes and quality assurance protocols in the Cannabis industry. In addition to participating in a recently published Cannabis genome sequencing project, Dr. Hudson been breeding specialized new varieties of Cannabis for both the medical marijuana and agricultural hemp market and has been active in studying effects of Cannabis in treating post traumatic stress disorder specifically working with military veterans to develop both medications and protocols. Dr. Hudson has spoken before the US Senate Committee on Veteran Affairs prior to the institution of ground- breaking legislation that allowed US veterans to receive recommendations for medical marijuana treatment in states with legal Cannabis programs. He has acted as a judge at Cannabis competitions and continues to speak at many international conferences.

Back To Top